IMCD N.V. (IMCD:AEX) - Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
Description
Report Summary
IMCD N.V. Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of IMCD N.V.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about IMCD N.V. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses IMCD N.V.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of IMCD N.V.'s overall strategic standing and supports informed decision-making and strategic planning.
The report also covers IMCD N.V.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares IMCD N.V.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by IMCD N.V. enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
IMCD N.V. is a leading global distribution partner and formulator of specialty chemicals and ingredients headquartered in Rotterdam, The Netherlands. Founded in 1995 under the management of Piet van der Slikke, the company emerged from a group of companies within Internatio-Muller that formed a separate division to become a new player in specialty chemicals distribution. The company was listed on the Euronext Stock Exchange in Amsterdam in 2014 and moved into the Dutch blue chip AEX index in 2019.Today, IMCD operates in more than 60 countries across six continents with over 5,126 employees worldwide. In 2024, the company achieved revenues of EUR 4,728 million with a gross profit of EUR 1,202 million. The company's global presence spans four main operating segments: EMEA (Europe, Turkey, Israel, Egypt, UAE, Saudi Arabia and Africa), Americas (USA, Canada, Brazil and Latin American countries), Asia-Pacific (Australia, New Zealand, India, China, Southeast Asia, Japan and South Korea), and Holding companies (including Rotterdam headquarters and regional offices). IMCD operates through eight business groups including Advanced Materials, Beauty & Personal Care, Coatings & Construction, Food & Nutrition, Home Care, Industrial Solutions, Lubricants & Energy, and Pharmaceuticals, providing technical expertise and market intelligence through its global network while maintaining sustainable growth through strategic acquisitions and operational excellence.
IMCD N.V. in the News:-
2025-08-21 - IMCD to showcase Where Taste Meets Texture at Fi India 2025
2025-07-16 - IMCD appoints Andreas Igerl to lead EMEA region and global Industrial Business Groups, and Narendra Varde to lead APAC region
2025-06-10 - Lubrizol Appoints IMCD to Grow Medical Solutions Business in North America
2025-04-30 - IMCD to showcase global innovation expertise and market trends at Saudi Arabia Coatings Show 2025
2025-04-25 - IMCD announces CEO transition
Scope
IMCD N.V. Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of IMCD N.V.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about IMCD N.V. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses IMCD N.V.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of IMCD N.V.'s overall strategic standing and supports informed decision-making and strategic planning.
The report also covers IMCD N.V.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares IMCD N.V.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by IMCD N.V. enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
IMCD N.V. is a leading global distribution partner and formulator of specialty chemicals and ingredients headquartered in Rotterdam, The Netherlands. Founded in 1995 under the management of Piet van der Slikke, the company emerged from a group of companies within Internatio-Muller that formed a separate division to become a new player in specialty chemicals distribution. The company was listed on the Euronext Stock Exchange in Amsterdam in 2014 and moved into the Dutch blue chip AEX index in 2019.Today, IMCD operates in more than 60 countries across six continents with over 5,126 employees worldwide. In 2024, the company achieved revenues of EUR 4,728 million with a gross profit of EUR 1,202 million. The company's global presence spans four main operating segments: EMEA (Europe, Turkey, Israel, Egypt, UAE, Saudi Arabia and Africa), Americas (USA, Canada, Brazil and Latin American countries), Asia-Pacific (Australia, New Zealand, India, China, Southeast Asia, Japan and South Korea), and Holding companies (including Rotterdam headquarters and regional offices). IMCD operates through eight business groups including Advanced Materials, Beauty & Personal Care, Coatings & Construction, Food & Nutrition, Home Care, Industrial Solutions, Lubricants & Energy, and Pharmaceuticals, providing technical expertise and market intelligence through its global network while maintaining sustainable growth through strategic acquisitions and operational excellence.
IMCD N.V. in the News:-
2025-08-21 - IMCD to showcase Where Taste Meets Texture at Fi India 2025
2025-07-16 - IMCD appoints Andreas Igerl to lead EMEA region and global Industrial Business Groups, and Narendra Varde to lead APAC region
2025-06-10 - Lubrizol Appoints IMCD to Grow Medical Solutions Business in North America
2025-04-30 - IMCD to showcase global innovation expertise and market trends at Saudi Arabia Coatings Show 2025
2025-04-25 - IMCD announces CEO transition
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
- Comprehensive Understanding of the IMCD N.V.'s internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
- IMCD N.V. Value Chain Analysis
- IMCD N.V. Porter's Five Forces Analysis
- IMCD N.V. VRIO Analysis
- IMCD N.V. BCG Analysis
- IMCD N.V. Segmentation, Targeting and Positioning (STP) Analysis
- IMCD N.V. Ansoff Matrix Analysis
Table of Contents
124 Pages
- Tables
- Charts
- IMCD N.V. - Key Company Facts
- IMCD N.V. - Company Description
- IMCD N.V. - Top Executives
- IMCD N.V.- Top Executives Biographies
- IMCD N.V.- Head Office & Locations
- Head Office - Country
- Key Subsidiaries
- IMCD N.V. - Products and Services
- Products
- Services
- IMCD N.V. - Historic Events
- IMCD N.V. – Company’s Management Discussion
- IMCD N.V. – Company’s Mission and Vision
- Mission
- Vision
- IMCD N.V. - Corporate Strategy
- IMCD N.V. - Business Description
- EMEA segment
- Americas segment
- Asia-Pacific segment
- Holding Companies
- IMCD N.V. - ESG Spotlight
- Environment
- Social
- Corporate Governance
- IMCD N.V. - SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- IMCD N.V. – PESTLE Analysis
- Overview
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Legal Factors
- Environmental Factors
- IMCD N.V. - Financial Deep Dive
- Share Price Trend - May-2024 to Dec-2025 (Average Share Closing Price)
- Profit and Loss Statement
- Summary of Profit and Loss Statement
- Balance Sheet
- Summary of Balance Sheet
- Cash Flow Statement
- Summary of Cash Flow Statement
- Key Financial Ratio Analysis
- IMCD N.V. - Ratio Charts
- Activity Ratio Charts
- Growth Ratios Charts
- Leverage Ratio Charts
- Liquidity Ratio Charts
- Profitability Ratio Charts
- Competing Players
- Snapshot of Competing Players
- Brenntag SE
- Key Company Facts
- Company Description
- Univar Solutions Inc
- Key Company Facts
- Company Description
- HELM AG
- Key Company Facts
- Company Description
- Wilbur Ellis Holdings Inc
- Key Company Facts
- Company Description
- Azelis Group NV
- Key Company Facts
- Company Description
- IMCD N.V. - In the News
- 21-Aug-2025 - IMCD to showcase ‘Where Taste Meets Texture’ at Fi India 2025
- 16-Jul-2025 - IMCD appoints Andreas Igerl to lead EMEA region and global Industrial Business Groups, and Narendra Varde to lead APAC region
- 10-Jun-2025 - Lubrizol Appoints IMCD to Grow Medical Solutions Business in North America
- 30-Apr-2025 - IMCD to showcase global innovation expertise and market trends at Saudi Arabia Coatings Show 2025
- 25-Apr-2025 - IMCD announces CEO transition 05-Mar-2025 - IMCD reports EBITA growth to EUR 531 million in 2024 03-Mar-2025 - IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets
- 13-Nov-2024 - IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares
- 24-Sep-2024 - From Strategy to Science: IMCD’s Investor Day and Lab Experience in Milan
- 29-Aug-2024 - IMCD successfully issues a EUR 500 million rated bond Press Release
- 27-Mar-2024 - IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- 10-Jan-2024 - IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market 09-Jan-2024 - IMCD strengthens its Executive Committee with two new appointments
- 23-Nov-2023 - IMCD appoints Dorthe Mikkelsen as member of the Supervisory Board
- IMCD N.V. - Key Deals
- 27-Aug-2025 - IMCD to acquire Tillmanns to further strengthen its presence in Italy
- 16-May-2025 - IMCD to acquire TECOM Ingredients to strengthen its offering in the food & nutrition market in Spain
- 18-Dec-2024 - IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets
- 13-Dec-2024 - IMCD China strengthens its life science business with the acquisition of Daoqin
- 17-Oct-2024 - IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- 10-Jun-2024 - IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- 24-Apr-2024 - IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- 20-Mar-2024 - IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- 16-Feb-2024 - IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem 01-Feb-2024 - IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited Press Release
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Financial Deep Dive
- Financial Ratios -
- Activity Ratios
- Growth Ratios
- Leverage Ratios
- Liquidity Ratios
- Market Ratios
- Profitability Ratios
- Research Methodology
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

